Vertex Treatment May Have High Risk of Failure, Analyst Suggests
March 24, 2015 at 15:13 PM EDT
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) recent results from a prospective cystic fibrosis treatment suggests the product has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.